Practical Fragments

This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments.

27 June 2022

CovPDB: a free, searchable database of covalent protein-ligand structures

›
Last week we highlighted KinaFrag, a database of kinase-fragment complexes. Continuing the theme, this week brings us CovPDB , a database o...
1 comment:
20 June 2022

KinaFrag: a free, searchable database of kinase fragments

›
Four of the six approved fragment-derived drugs are kinase inhibitors, and three of these bind in the active site. Despite these successes,...
13 June 2022

Fragments vs HIV-1 Protease: Pocket-to-Lead

›
The drugging of HIV-1 protease is a classic structure-based design success story, as discussed in a guest post by Glyn Williams from the ea...
06 June 2022

What to make first? A new “Ring Replacement Recommender” provides suggestions

›
So you’ve run a fragment screen, gotten some hits, and validated them. What then? Looking for in-house or commercial analogs is always a go...
1 comment:
30 May 2022

Covalent fragments vs Rgl2

›
Just over a year ago the FDA granted accelerated approval to sotorasib , the first marketed inhibitor of KRAS and the first approved fragme...
23 May 2022

A fragment-sized chemical probe for Notum

›
Practical Fragments has written previously ( here and here ) about the enzyme Notum, which shuts down Wnt signaling by removing a palmitoy...
1 comment:
16 May 2022

SAMPL7: Epic computational fail or just no solution?

›
Every few years computational chemists are invited to compete in the Statistical Assessment of Proteins and Ligands (SAMPL) challenges. Rese...
6 comments:
09 May 2022

Fragments vs TLR7/8, starting from HTS

›
The toll-like receptors TLR7 and TLR8 are closely related proteins that respond to single-stranded RNA, often associated with viral infectio...
02 May 2022

Fragment events in 2022 and 2023

›
The first third of 2022 has already been graced with two major fragment conferences. Two more have recently been added, and 2023 is starting...
25 April 2022

Seventeenth Annual Fragment-Based Drug Discovery Meeting

›
Last week the CHI Drug Discovery Chemistry (DDC) meeting returned triumphantly to San Diego. This was the best conference I’ve attended in ...
1 comment:
18 April 2022

Fragments win in a virtual screen against Notum

›
Wnt proteins are implicated in a variety of diseases, from Alzheimer’s to colorectal cancer. The enzyme Notum shuts down signaling by removi...
11 April 2022

Nucleophilic fragments vs SARM1: in situ inhibitor assembly

›
Recently Practical Fragments wrote about nucleophilic fragments that could react with proteins or cofactors. Previously we’ve also written...
01 April 2022

Fragments in space!

›
Practical Fragments has discussed fragments on Mars and Venus , but those planets are just two small specks in a vast universe. Always thi...
2 comments:
28 March 2022

Why HDX-MS is rare in FBLD – and practical tips to change this

›
Hydrogen/deuterium exchange mass spectrometry (HDX-MS) can help identify the binding site of a ligand, sometimes. Briefly, a protein-ligand ...
21 March 2022

Nucleophilic fragments: the other kind of covalent inhibitors

›
Covalent fragment-based lead discovery is becoming increasingly popular , spurred on by the rapid discovery and approval of sotorasib . In g...
14 March 2022

Higher hit rates with heavier halogens

›
Halogen bonding is an esoteric type of molecular interaction. Any first-year chemistry student can tell you that halogens are electronegati...
07 March 2022

Virtual screening succeeds against the SARS-CoV-2 main protease

›
Today marks exactly two years since Practical Fragments first mentioned SARS-CoV-2. Since then, COVID-19 has killed more than 6 million pe...
28 February 2022

Photoaffinity fragment PhABits, faster

›
Practical Fragments has written previously about PhotoAffinity Bits, or PhABits , which are fragments designed to reveal binding (as oppose...
‹
›
Home
View web version
Powered by Blogger.